Ausgabe 3/2012
Inhalt (22 Artikel)
Androgen receptor footprint on the way to prostate cancer progression
Myles C. Hodgson, Wayne A. Bowden, Irina U. Agoulnik
Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives
Nagalakshmi Nadiminty, Allen C. Gao
Androgen receptor co-activators in the regulation of cellular events in prostate cancer
Zoran Culig, Frédéric R. Santer
NF-κB signaling in prostate cancer: A promising therapeutic target?
Garima Jain, Marcus V. Cronauer, Mark Schrader, Peter Möller, Ralf B. Marienfeld
Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer
Marianne D. Sadar
ID4 is frequently downregulated and partially hypermethylated in prostate cancer
Anna Vinarskaja, Wolfgang Goering, Marc Ingenwerth, Wolfgang A. Schulz
Effect of the heat shock protein HSP27 on androgen receptor expression and function in prostate cancer cells
Matthias B. Stope, Tina Schubert, Doreen Staar, Cindy Rönnau, Andreas Streitbörger, Nils Kroeger, Constanze Kubisch, Uwe Zimmermann, Reinhard Walther, Martin Burchardt
AR-Q640X, a model to study the effects of constitutively active C-terminally truncated AR variants in prostate cancer cells
Wolfgang Streicher, Friedemann Zengerling, Martin Laschak, Wolfgang Weidemann, Michael Höpfner, Andres J. Schrader, Florian Jentzmik, Mark Schrader, Marcus V. Cronauer
Value of enhanced transrectal ultrasound targeted biopsy for prostate cancer diagnosis: a retrospective data analysis
Friedrich Aigner, Georg Schäfer, Eberhard Steiner, Werner Jaschke, Wolfgang Horninger, Thomas R. W. Herrmann, Udo Nagele, Ethan J. Halpern, Ferdinand Frauscher
When is it necessary to perform nuclear renogram in patients with a unilateral neonatal hydronephrosis?
Berk Burgu, Ozgu Aydogdu, Tarkan Soygur, Linda Baker, Warren Snodgrass, Duncan Wilcox
Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma
B. Amend, J. Hennenlotter, M. Scharpf, S. Kruck, U. Kuehs, E. Senger, A. S. Merseburger, M. A. Kuczyk, K. D. Sievert, A. Stenzl, J. Bedke
Low testosterone bioavailability is related to prostate cancer diagnose in patients submitted to prostate biopsy
Eduard García-Cruz, Jorge Huguet, Marta Piqueras, Meritxell Pérez Márquez, Lluís Peri, Laura Izquierdo, Agustín Franco, Ricardo Álvarez-Vijande, María José Ribal, Antonio Alcaraz
Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment
S. H. Alloussi, Ch. Lang, R. Eichel, A. Al-Kaabneh, J. Seibold, C. Schwentner, S. Alloussi
The clinical impact of pathological review on selection the treatment modality for localized prostate cancer in candidates for brachytherapy monotherapy
Ryo Kishimoto, Takashi Saika, Kensuke Bekku, Hiroyuki Nose, Fernando Abarzua, Yasuyuki Kobayashi, Motoo Araki, Hiroyuki Yanai, Yasutomo Nasu, Hiromi Kumon
Oncologic outcomes following radical prostatectomy with intraoperative cell salvage
Michael A. Gorin, Ahmed Eldefrawy, Murugesan Manoharan, Mark S. Soloway
Urinary urgency: a review of its assessment as the key symptom of the overactive bladder syndrome
Paul Abrams, Christopher R. Chapple, Klaus-Peter Jünemann, Steven Sharpe
Prospective comparison of short-term functional outcomes obtained after pure laparoscopic and robot-assisted laparoscopic sacrocolpopexy
Julien Seror, David R. Yates, Elise Seringe, Christophe Vaessen, Marc-Olivier Bitker, Emmanuel Chartier-Kastler, Morgan Rouprêt
Central venous port implantations via the cephalic vein applying an intravasal electrographic control of the catheter tip position: a single-center experience of 316 cases
Marcus Schenck, Tim Schneider, Herbert Rübben, Andreas Eisenhardt
Age-specific PCA3 score reference values for diagnosis of prostate cancer
Tobias Klatte, Matthias Waldert, Michela de Martino, Georg Schatzl, Christine Mannhalter, Mesut Remzi
Enhanced urothelial expression of human chorionic gonadotropin beta (hCGβ) in bladder pain syndrome/interstitial cystitis (BPS/IC)
Thilo Schwalenberg, Jens-Uwe Stolzenburg, Phuc Ho Thi, Tobias Mallock, Siegurd Hartenstein, Henry Alexander, Gerolf Zimmermann, Rudolf Hohenfellner, Stefan Denzinger, Maximilian Burger, Lars-Christian Horn, Jochen Neuhaus
Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia
Richard-Olivier Fourcade, François Lacoin, Morgan Rouprêt, Alain Slama, Camille Le Fur, Emilie Michel, Axel Sitbon, François-Emery Cotté